How does HIV impact on non-AIDS events in the era of HAART?

被引：8

作者：

Barber, T. J. ^{[1
]}

Hughes, A. ^{[2
]}

Dinsmore, W. W. ^{[3
]}

Phillips, A. ^{[4
]}

机构：

[1] Mortimer Market Ctr, Camden Primary Care Trust, London WC1E 6JB, England

[2] Chelsea & Westminster NHS Fdn Trust, St Stephens Ctr, London SW10 9NH, England

[3] Royal Victoria Hosp, Belfast BT12 6BA, Antrim, North Ireland

[4] Royal Free & Univ Coll Med Sch, HIV Epidemiol & Biostat Grp, London WC1E 6BT, England

来源：

INTERNATIONAL JOURNAL OF STD & AIDS | 2009年 / 20卷 / 01期

关键词：

HIV; HAART; non-AIDS events; mortality; IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL DEPLETION; ANTIRETROVIRAL THERAPY; GASTROINTESTINAL-TRACT; INFECTION; DISEASE; ASSOCIATION; LYMPHOCYTES; OUTCOMES;

D O I：

10.1258/ijsa.2008.008302

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Death rates from AIDS-related events in HIV-positive individuals have declined in the era of highly active antiretroviral therapy (HAART). It has also been shown that deaths from non-AIDS events have declined in this cohort since the advent of HAART. We review these data, as well as discussing some of the possible effects HAART might have on non-AIDS diagnoses and deaths in HIV-positive individuals with successfully treated HIV.

引用

页码：1 / 3

页数：3

共 20 条

[1]

[Anonymous], 2008, Physical activity guidelines for Americans, P1

[2]

BAKER J, 2007, 14 C RETR OPP INF LO

[3] CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract [J].

Brenchley, JM ;

Schacker, TW ;

Ruff, LE ;

Price, DA ;

Taylor, JH ;

Beilman, GJ ;

Nguyen, PL ;

Khoruts, A ;

Larson, M ;

Haase, AT ;

Douek, DC .

JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (06) :749-759

[4]

DEGAETANO DK, 2004, LANCET INFECT DIS, V4, P213, DOI DOI 10.1016/S1473-3099(04)00971-5

[5]

El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360

[6] Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study [J].

Emery, Sean ;

Neuhaus, Jacqueline A. ;

Phillips, Andrew N. ;

Babiker, Abdel ;

Cohen, Calvin J. ;

Gatell, Jose M. ;

Girard, Pierre-Marie ;

Grund, Birgit ;

Law, Matthew ;

Losso, Marcelo H. ;

Palfreeman, Adrian ;

Wood, Robin .

JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (08) :1133-1144

[7] British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008 [J].

Gazzard, B. G. .

HIV MEDICINE, 2008, 9 (08) :563-608

[8] Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy [J].

Guadalupe, M ;

Reay, E ;

Sankaran, S ;

Prindiville, T ;

Flamm, J ;

McNeil, A ;

Dandekar, S .

JOURNAL OF VIROLOGY, 2003, 77 (21) :11708-11717

[9] C-reactive protein is a marker for human immunodeficiency virus disease progression [J].

Lau, B ;

Sharrett, AR ;

Kingsley, LA ;

Post, W ;

Palella, FJ ;

Visscher, B ;

Gange, SJ .

ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (01) :64-70

[10]

LIM SG, 1993, CLIN EXP IMMUNOL, V92, P448, DOI 10.1111/j.1365-2249.1993.tb03419.x

← 1 2 →